ZYNDIO

GLP-1 weight loss care

Contact About FAQ

Telehealth Login Get started

Home
Blog
ED

Category

ED

PDE5 inhibitors (tadalafil, sildenafil), daily-dose strategies, cardiac safety, and when these medications are not appropriate.

No articles in this category yet.

ZYNDIO

Physician-led telehealth care

ZYNDIO publishes physician-reviewed therapy pathways for weight loss, NAD+, and erectile dysfunction care. A licensed doctor reviews every eligible case, and any prescriptions ship from U.S.-licensed pharmacies only after physician approval.

Resources

About
Contact
FAQ
Blog
Sitemap
Ambassador Program

What We Treat

Weight Loss
NAD+ Nasal
NAD+ Injection
Erectile Dysfunction

Legal

Privacy Policy
Returns & Refund
HIPAA Notice
Terms of Use
Telehealth Consent

Built with compliance in mind.

ZYNDIO keeps clinical, pharmacy, privacy, and payment workflows in controlled lanes.

Board-certified physician review and pharmacy handoff stay separate.
Health-related information is routed through approved clinical systems where applicable.
Consent records and audit-friendly boundaries stay built in.

SOC 2 Type I preparation

ZYNDIO is preparing for an independent SOC 2 Type I examination covering the Security Trust Services Criteria for our production platform.

HIPAA privacy practices badge

HIPAA privacy practices

PHI workflows are governed by the HIPAA Notice of Privacy Practices where applicable.

GDPR data protection regulation badge

Privacy controls

Consent-aware data handling supports cleaner routing and less exposure.

CCPA consumer privacy badge

Consumer privacy

Privacy notices, data boundaries, and consumer-rights workflows stay built in.

Verify Approval for www.zyndio.com

LegitScript approved

Click the seal to verify LegitScript approval for www.zyndio.com.

Email: care@zyndio.comPhone: (307) 227 9322Address: Zyndio, LLC, 30 N Gould St Ste R, Sheridan, WY 82801, USA

© 2026 ZYNDIO. All rights reserved.